CN Patent

CN106674294B — 吡喃葡萄糖基衍生物的结晶形式

Assigned to Yichang Hec Changjiang Pharmaceutical Co ltd · Expires 2020-07-07 · 6y expired

What this patent protects

本发明涉及作为钠依赖性葡萄糖转运蛋白(SGLT)抑制剂的吡喃葡萄糖基衍生物的晶型、其制备方法及其在医药上的应用，还涉及含有这些晶型的药物组合物和它们用于制备治疗糖尿病和/或糖尿病相关疾病的药物的用途。

USPTO Abstract

本发明涉及作为钠依赖性葡萄糖转运蛋白(SGLT)抑制剂的吡喃葡萄糖基衍生物的晶型、其制备方法及其在医药上的应用，还涉及含有这些晶型的药物组合物和它们用于制备治疗糖尿病和/或糖尿病相关疾病的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN106674294B
Jurisdiction: CN
Classification: —
Expires: 2020-07-07
Drug substance claim: No
Drug product claim: No
Assignee: Yichang Hec Changjiang Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.